TG Therapeutics, Inc. Gross Profit 2011–2025
TG Therapeutics, Inc. reported $515.57M of gross profit for fiscal 2025. That was 77.5% higher than fiscal 2024. Compared with fiscal 2021, the change was +8640.0%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $515.57M | 83.7% | +77.5% |
| FY 2024 | $290.52M | 88.3% | +32.3% |
| FY 2023 | $219.53M | 94.0% | +8611.5% |
| FY 2022 | $2.52M | 90.5% | -57.3% |
| FY 2021 | $5.90M | 88.2% | — |
| FY 2020 | — | — | — |
| FY 2019 | — | — | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
| FY 2016 | — | — | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
Source: TG Therapeutics, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TGTX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
TG Therapeutics, Inc. reported $515.57M of gross profit for fiscal 2025. That was 77.5% higher than fiscal 2024. Compared with fiscal 2021, the change was +8640.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s gross profit?
TG Therapeutics, Inc. (TGTX) reported gross profit of $515.57M for fiscal year 2025, per its SEC filings.
How has TG Therapeutics, Inc.'s gross profit changed over time?
Between fiscal 2011 and 2025, TGTX's gross profit grew at roughly 37.6% per year (compound annual rate), from $5.90M to $515.57M.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.